Device Stakeholders Debate Whether FDA Can, Or Should, Revoke 510(k)s
This article was originally published in The Gray Sheet
Executive Summary
FDA should have no reason to rescind 510(k) substantial equivalence decisions for marketed devices except in extreme cases of fraud, device industry lobbyists said in recent comments to FDA